Alirocumab in Patients on a Stable Dialysis Regimen
Alirocumab in Patients on a Stable Dialysis Regimen
Recruiting · NCT03480568 · Registry updated 2020-02-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Alirocumab in Patients on a Stable Dialysis Regimen | Dyslipidemias, Hypercholesterolemia, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, hyperlipidemia, metabolic disease | Recruiting | Phase 3 | 2020-02-12 | NCT03480568 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Baylor Research Institute | 66 |
| Regeneron Pharmaceuticals | 238 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Baylor Soltero CV Research | Dallas | United States | 1 |